10 principais crisprtx.com concorrentes

synthego.com

This tech note takes a closer look at a new high throughput method to evaluate novel nucleases leveraging Synthego's Halo™ Platform for Synthetic sgRNA and automation capabilities coupled with Paragon Genomics' ClearPlex™ amplicon sequencing technology.

ksqtx.com

CAMBRIDGE, Mass., September 22, 2021 – KSQ Therapeutics, a biotechnology company developing drugs to treat cancer and autoimmune diseases using its proprietary, integrated discovery platform to systematically screen the whole genome in cancer and immune cells, today announced that Qasim Rizvi, Chief Executive Officer of KSQ, will present at the 2021 Cantor Virtual Global Healthcare

scribetx.com

We’re always looking for individuals with drive, creativity, pragmatism, and integrity to join our team.

orukatx.com

oruka is developing novel biologics that aim to offer the greatest possible freedom from disease to people affected by chronic skin conditions

capsida.com

Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.

asgct.org

The unbiased source for reliable, scientific information, news, and breakthroughs in gene and cell therapy.

broadinstitute.org

The Broad Institute’s mission is to understand the roots of disease and close the gap between new biological insights and impact for patients. Here’s how our research — much of it federally funded — is improving human health and accelerating biomedical discoveries.

modernatx.com

Moderna’s Terms of Use

alnylam.com

Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational medicines for patients.

biontech.de

BioNTech guides you through the promising world of immunotherapies. Find information on basic research and new developments of new treatment options.